ADVM
Price
$2.75
Change
+$0.33 (+13.64%)
Updated
Jun 6, 01:41 PM (EDT)
Capitalization
50.66M
TENX
Price
$5.90
Change
+$0.02 (+0.34%)
Updated
Jun 6, 11:16 AM (EDT)
Capitalization
24.39M
Interact to see
Advertisement

ADVM vs TENX

Header iconADVM vs TENX Comparison
Open Charts ADVM vs TENXBanner chart's image
Adverum Biotechnologies
Price$2.75
Change+$0.33 (+13.64%)
Volume$566
Capitalization50.66M
Tenax Therapeutics
Price$5.90
Change+$0.02 (+0.34%)
Volume$710
Capitalization24.39M
ADVM vs TENX Comparison Chart
Loading...
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADVM vs. TENX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADVM is a Buy and TENX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ADVM: $2.42 vs. TENX: $5.88)
Brand notoriety: ADVM and TENX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADVM: 23% vs. TENX: 78%
Market capitalization -- ADVM: $50.66M vs. TENX: $24.39M
ADVM [@Biotechnology] is valued at $50.66M. TENX’s [@Biotechnology] market capitalization is $24.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADVM’s FA Score shows that 0 FA rating(s) are green whileTENX’s FA Score has 1 green FA rating(s).

  • ADVM’s FA Score: 0 green, 5 red.
  • TENX’s FA Score: 1 green, 4 red.
According to our system of comparison, TENX is a better buy in the long-term than ADVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADVM’s TA Score shows that 5 TA indicator(s) are bullish while TENX’s TA Score has 5 bullish TA indicator(s).

  • ADVM’s TA Score: 5 bullish, 3 bearish.
  • TENX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ADVM is a better buy in the short-term than TENX.

Price Growth

ADVM (@Biotechnology) experienced а +7.30% price change this week, while TENX (@Biotechnology) price change was -4.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.36%. For the same industry, the average monthly price growth was +17.11%, and the average quarterly price growth was +3.22%.

Reported Earning Dates

ADVM is expected to report earnings on Apr 15, 2025.

TENX is expected to report earnings on Mar 25, 2025.

Industries' Descriptions

@Biotechnology (+11.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ADVM($50.7M) has a higher market cap than TENX($24.4M). TENX YTD gains are higher at: -5.008 vs. ADVM (-48.073). TENX has higher annual earnings (EBITDA): -14.53M vs. ADVM (-99.25M). ADVM has more cash in the bank: 153M vs. TENX (98.3M). TENX has less debt than ADVM: TENX (279K) vs ADVM (73.3M). ADVM has higher revenues than TENX: ADVM (1M) vs TENX (0).
ADVMTENXADVM / TENX
Capitalization50.7M24.4M208%
EBITDA-99.25M-14.53M683%
Gain YTD-48.073-5.008960%
P/E RatioN/A3.48-
Revenue1M0-
Total Cash153M98.3M156%
Total Debt73.3M279K26,272%
FUNDAMENTALS RATINGS
ADVM vs TENX: Fundamental Ratings
ADVM
TENX
OUTLOOK RATING
1..100
27
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
20
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9592
PRICE GROWTH RATING
1..100
9646
P/E GROWTH RATING
1..100
10055
SEASONALITY SCORE
1..100
95n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TENX's Valuation (20) in the Medical Specialties industry is in the same range as ADVM (40) in the Biotechnology industry. This means that TENX’s stock grew similarly to ADVM’s over the last 12 months.

TENX's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ADVM (100) in the Biotechnology industry. This means that TENX’s stock grew similarly to ADVM’s over the last 12 months.

TENX's SMR Rating (92) in the Medical Specialties industry is in the same range as ADVM (95) in the Biotechnology industry. This means that TENX’s stock grew similarly to ADVM’s over the last 12 months.

TENX's Price Growth Rating (46) in the Medical Specialties industry is somewhat better than the same rating for ADVM (96) in the Biotechnology industry. This means that TENX’s stock grew somewhat faster than ADVM’s over the last 12 months.

TENX's P/E Growth Rating (55) in the Medical Specialties industry is somewhat better than the same rating for ADVM (100) in the Biotechnology industry. This means that TENX’s stock grew somewhat faster than ADVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADVMTENX
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TENX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LE8.941.03
+13.00%
Lands' End
BDX171.030.09
+0.05%
Becton Dickinson and Co
GTM9.97N/A
N/A
ZOOMINFO Technologies Inc.
VTEX6.60N/A
N/A
VTEX
ACCS9.83-0.32
-3.15%
ACCESS Newswire Inc

TENX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TENX has been loosely correlated with AVXL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TENX jumps, then AVXL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TENX
1D Price
Change %
TENX100%
+0.34%
AVXL - TENX
47%
Loosely correlated
+0.65%
SBHMY - TENX
42%
Loosely correlated
N/A
CORT - TENX
41%
Loosely correlated
-1.33%
ADVM - TENX
36%
Loosely correlated
-1.82%
LOGC - TENX
33%
Loosely correlated
+3.89%
More